Immune Responses to Schistosome Egg Antigens
Immune Responses to Schistosome Egg Antigens
批准号:
7897825
负责人:
Donald A Harn
金额:
$37.42万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2003
资助国家:
美国
项目状态:
已结题
起止时间:
2003-07-22 至 2012-06-30
关键词:
AdultAnti-Inflammatory AgentsAnti-inflammatoryAntigen-Presenting CellsAntigensAutoimmune DiseasesAutomobile DrivingBindingBlocking AntibodiesBlood CirculationC Type Lectin ReceptorsC-Type LectinsCD209 geneCandidate Disease GeneCarbohydratesCellsDataDendritic CellsDiseaseEndosomesGenesGlycoconjugatesGoalsHumanImmuneImmune responseImmunosuppressionIn VitroInfectionInflammation MediatorsInflammatoryInflammatory ResponseInjection of therapeutic agentInterleukin-10Interleukin-13Interleukin-17Interleukin-4Interleukin-6IntestinesKnowledgeLectinLigandsLigationLiverMacrophage ActivationMeasuresMediatingMedicineMesenteryMicroarray AnalysisMusParasitesPhenotypePlayPolysaccharidesPongidaeProcessProductionProgress ReportsProteinsReceptor SignalingRegulatory T-LymphocyteRoleSchistosomaSchistosoma mansoniSignal PathwaySignal TransductionSignaling MoleculeSmall Interfering RNAT cell responseT-LymphocyteTLR4 geneToll-like receptorsTravelbaseeggfeedinggalactose receptorimmunopathologyimmunoregulationin vivoinhibitor/antagonistinterleukin-23lacto-N-fucopentaose IIIlymph nodesmacrophagemannose receptorneutralizing antibodypreventreceptorresearch studyresponse
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Previously we demonstrated that schistosome egg glycans are largely responsible for parasite induced immunomodulation and Th2-biasing. We identified LNFPIII and LNnT as two glycans present on schistosome eggs that drive immune modulation in vifro and in vivo. These glycans induce immune suppression and CD4+ Th2-type responses when presented 10 antigen presenting cells as glyco-conjugales. The overall goal of this renewal application is to understand how defined schistosome glycans activate APCs in such a manner that these APCs drive anti-inflammatory responses. Alternative activation of human DCs by soluble egg antigens occurs through three Ctype lectins: mannose receptor (MR), macrophage galactose receptor (MgI) and DC-SIGN. LNFPIlI binds to each of these lectins and to MSIGNR1 . Therefore we will perform experiments in mice deficient in these lectins or use HEK cells singly transfected with these lectins to examine their roles in LNFPIII induced APC activation. In addition, by transfecting HEK cells expressing TLR4/CD14/MD2 with these same C-type lectins we will determine if activation of APes via these lectins alters Toll-like receptor induced signaling. Because C-type lectin-ligand interaction leads to endosome formation, we will examine the role endosome formation plays in alternative activation using inhibitors of endosome formation. We have performed microarray analysis to examine signaling pathways downstream of LNFPlIl activation and Identify candidate genes. We will use RT -PCR to validate several candidate genes and then siRNA to knockdown these genes to determine if their role is critical for alternative activation. For proteins we will use Rules Based Medicine (RBM) analysis to measure levels of >72 proteins known to be involved in innate activation of APCs. The specific aims are: 1) What roles do specific C-type lectins and endosome formation play in driving LNFPIII induction of alternative activation of APCs? 2) Determine if candidate signaling molecules and soluble factors are required for LNFPIII induced altemative activation of APCs?
期刊论文(14)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Dendritic cells activated by an anti-inflammatory agent induce CD4(+) T helper type 2 responses without impairing CD8(+) memory and effector cytotoxic T-lymphocyte responses.
抗炎剂激活的树突状细胞可诱导 CD4( ) T 辅助细胞 2 型反应,而不损害 CD8( ) 记忆和效应细胞毒性 T 淋巴细胞反应。
DOI:
10.1111/j.1365-2567.2009.03193.x
发表时间:
2010
期刊:
Immunology
影响因子:
6.4
作者:
[Wang,Yang, Da'Dara,AkramA, Thomas,PaulG, Harn,DonaldA]
通讯作者:
Harn,DonaldA
DOI:
10.1021/cb400944y
发表时间:
2014-05-16
期刊:
ACS CHEMICAL BIOLOGY
影响因子:
4
作者:
[Pathak, Rakesh K., Marrache, Sean, Harn, Donald A., Dhar, Shanta]
通讯作者:
Dhar, Shanta
DOI:
10.1039/c2ib20125a
发表时间:
2013-01
期刊:
Integrative biology : quantitative biosciences from nano to macro
影响因子:
--
作者:
[Marrache S, Choi JH, Tundup S, Zaver D, Harn DA, Dhar S]
通讯作者:
Dhar S
Ex vivo generation of functional immune cells by mitochondria-targeted photosensitization of cancer cells.
通过癌细胞的线粒体靶向光敏作用离体产生功能性免疫细胞。
DOI:
10.1007/978-1-4939-2288-8_9
发表时间:
2015
期刊:
Methods in molecular biology (Clifton, N.J.)
影响因子:
--
作者:
[Marrache,Sean, Tundup,Smanla, Harn,DonaldA, Dhar,Shanta]
通讯作者:
Dhar,Shanta
Polarization of host immune responses by helminth-expressed glycans.
蠕虫表达的聚糖对宿主免疫反应的极化。
DOI:
10.1111/j.1749-6632.2012.06618.x
发表时间:
2012
期刊:
Annals of the New York Academy of Sciences
影响因子:
5.2
作者:
[Tundup,Smanla, Srivastava,Leena, HarnJr,DonaldA]
通讯作者:
HarnJr,DonaldA
共 7 条
The Effect of Helminth Infection on HIV-1 Vaccines
-
批准号:7877043
-
项目类别:
-
资助金额:$37.22万
-
财政年份:2009
-
负责人:Donald A Harn
-
依托单位:
The Effect of Helminth Infection on HIV-1 Vaccines
-
批准号:7418170
-
项目类别:
-
资助金额:$37.1万
-
财政年份:2009
-
负责人:Donald A Harn
-
依托单位:
Effect of Helminth Infection on HIV-1 Vaccines
-
批准号:7923569
-
项目类别:
-
资助金额:$25.91万
-
财政年份:2008
-
负责人:Donald A Harn
-
依托单位:
Effect of Helminth Infection on HIV-1 Vaccines
-
批准号:7760839
-
项目类别:
-
资助金额:$36.75万
-
财政年份:2008
-
负责人:Donald A Harn
-
依托单位:
Effect of Helminth Infection on HIV-1 Vaccines
-
批准号:7494355
-
项目类别:
-
资助金额:$40.75万
-
财政年份:2008
-
负责人:Donald A Harn
-
依托单位:
Effect of Helminth Infection on HIV-1 Vaccines
-
批准号:7565900
-
项目类别:
-
资助金额:$12.38万
-
财政年份:2008
-
负责人:Donald A Harn
-
依托单位:
Effect of Helminth Infection on HIV-1 Vaccines
-
批准号:8013546
-
项目类别:
-
资助金额:$36.39万
-
财政年份:2008
-
负责人:Donald A Harn
-
依托单位:
Effect of Helminth Infection on HIV-1 Vaccines
-
批准号:8213688
-
项目类别:
-
资助金额:$36.39万
-
财政年份:2008
-
负责人:Donald A Harn
-
依托单位:
Prophylactic Vaccines for Schistosomiasis
-
批准号:7923601
-
项目类别:
-
资助金额:$31.76万
-
财政年份:2007
-
负责人:Donald A Harn
-
依托单位:
Prophylactic Vaccines for Schistosomiasis
-
批准号:7782810
-
项目类别:
-
资助金额:$40.24万
-
财政年份:2007
-
负责人:Donald A Harn
-
依托单位:
Prophylactic Vaccines for Schistosomiasis
-
批准号:7591665
-
项目类别:
-
资助金额:$11.6万
-
财政年份:2007
-
负责人:Donald A Harn
-
依托单位:
Prophylactic Vaccines for Schistosomiasis
-
批准号:8049652
-
项目类别:
-
资助金额:$39.93万
-
财政年份:2007
-
负责人:Donald A Harn
-
依托单位:
Prophylactic Vaccines for Schistosomiasis
-
批准号:7259695
-
项目类别:
-
资助金额:$38.87万
-
财政年份:2007
-
负责人:Donald A Harn
-
依托单位:
Prophylactic Vaccines for Schistosomiasis
-
批准号:7387339
-
项目类别:
-
资助金额:$40.42万
-
财政年份:2007
-
负责人:Donald A Harn
-
依托单位:
Immune Responses to Schistosome Egg Antigens
-
批准号:6830823
-
项目类别:
-
资助金额:$41.76万
-
财政年份:2003
-
负责人:Donald A Harn
-
依托单位:
Immune Responses to Schistosome Egg Antigens
-
批准号:7010718
-
项目类别:
-
资助金额:$42.0万
-
财政年份:2003
-
负责人:Donald A Harn
-
依托单位:
HIV Vaccines in Th2 Biased Recipients
-
批准号:6655405
-
项目类别:
-
资助金额:$24.54万
-
财政年份:2003
-
负责人:Donald A Harn
-
依托单位:
Immune Responses to Schistosome Egg Antigens
-
批准号:7525378
-
项目类别:
-
资助金额:$37.4万
-
财政年份:2003
-
负责人:Donald A Harn
-
依托单位:
Immune Responses to Schistosome Egg Antigens
-
批准号:6767828
-
项目类别:
-
资助金额:$40.48万
-
财政年份:2003
-
负责人:Donald A Harn
-
依托单位:
Immune Responses to Schistosome Egg Antigens
-
批准号:6687522
-
项目类别:
-
资助金额:$19.62万
-
财政年份:2003
-
负责人:Donald A Harn
-
依托单位:
海外基金